Andrea Gonzalez-Munoz

After completing a PhD in Immunogenetics at the University of Cambridge in 2000 (Babraham Institute), Andrea obtained a postdoctoral fellow position to focus on the identification and characterisation of genes that contributes to Diabetes Type I susceptibility at the JDRF/WT Diabetes and Inflammation Laboratory, CIMR (Cambridge Institute of Medical Research), Addenbrooke’s Hospital, Cambridge, UK. In 2007, Andrea joined the Technology Department at Cambridge Antibody Technology (CAT) that later become MedImmune. For several years, Andrea has been working in phenotypic screening covering novel target discovery, protein engineering and novel therapeutic platforms in the Antibody Discovery and Protein Engineering Department at MedImmune.